The House of Representatives last night voted 234-183 to pass legislation (H.R. 987) that combines several AHA-supported bills to help lower prescription drug costs and strengthen the Affordable Care Act’s health insurance marketplaces. The legislation’s drug-related provisions would allow generic drug manufacturers facing certain anticompetitive delay tactics to bring an action in federal court for injunctive relief, and help decrease the time it takes for generic competitors to get to market. The ACA marketplace provisions would provide funding to expand navigator support and outreach to help consumers enroll in individual market coverage, and void a final rule that expanded short-term limited duration health plans. 
 

Related News Articles

Headline
Six national organizations, including the AHA, today urged congressional leaders to permanently expand access to the Affordable Care Act’s advance premium tax…
Headline
A new report released by the Department of Health and Human Services today indicates that the nation’s uninsured rate reached an all-time low by the end of…
Headline
The Biden Administration today announced a proposed rule to fix what is called the “family glitch” — a known gap in the Affordable Care Act that inaccurately…
News
Over 14.5 million people selected or were automatically re-enrolled in a health plan through the federally facilitated or state-based marketplaces during 2022…
Headline
In a statement submitted to the Senate Finance Committee for a hearing yesterday on lowering drug prices in Medicare, AHA encouraged Congress to implement…
News
Drug companies raised prices faster than inflation for about half of all drugs covered by Medicare between July 2019 and July 2020, according to an analysis…